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Schrauwen, Patrick, Matthijs K. C. Hesselink, Ilonca
Vaartjes, Esther Kornips, Wim H. M. Saris, Jean-Paul
Giacobino, and Aaron Russell. Effect of acute exercise on
uncoupling protein 3 is a fat metabolism-mediated effect. Am
J Physiol Endocrinol Metab 282: E11–E17, 2002.—Human
and rodent uncoupling protein (UCP)3 mRNA is upregulated
after acute exercise. Moreover, exercise increases plasma levels
of free fatty acid (FFA), which are also known to upregulate
UCP3. We investigated whether the upregulation of UCP3 after
exercise is an effect of exercise per se or an effect of FFA levels
or substrate oxidation. Seven healthy untrained men [age:
22.7 6 0.6 yr; body mass index: 23.8 6 1.0 kg/m2; maximal O2
uptake (V˙O2 max): 3,852 6 211 ml/min] exercised at 50% V˙O2 max
for 2 h and then rested for 4 h. Muscle biopsies and blood
samples were taken before and immediately after 2 h of exercise
and 1 and 4 h in the postexercise period. To modulate plasma
FFA levels and fat/glucose oxidation, the experiment was per-
formed two times, one time with glucose ingestion and one time
while fasting. UCP3 mRNA and UCP3 protein were determined
by RT-competitive PCR and Western blot. In the fasted state,
plasma FFA levels significantly increased (P , 0.0001) during
exercise (293 6 25 vs. 1,050 6 127 mmol/l), whereas they were
unchanged after glucose ingestion (335 6 54 vs. 392 6 74
mmol/l). Also, fat oxidation was higher after fasting (P , 0.05),
whereas glucose oxidation was higher after glucose ingestion
(P , 0.05). In the fasted state, UCP3L mRNA expression was
increased significantly (P , 0.05) 4 h after exercise (4.6 6 1.2 vs.
9.6 6 3.3 amol/mg RNA). This increase in UCP3L mRNA ex-
pression was prevented by glucose ingestion. Acute exercise had
no effect on UCP3 protein levels. In conclusion, we found that
acute exercise had no direct effect on UCP3 mRNA expression.
Abolishing the commonly observed increase in plasma FFA
levels and/or fatty acid oxidation during and after exercise
prevents the upregulation of UCP3 after acute exercise. There-
fore, the previously observed increase in UCP3 expression ap-
pears to be an effect of prolonged elevation of plasma FFA levels
and/or increased fatty acid oxidation.
fat oxidation; uncoupling protein; fatty acids; mitochondria
THE HUMAN UNCOUPLING PROTEIN (UCP) 3 uncouples the
respiratory chain, producing heat without an increase
in ATP production, and is therefore suggested to play a
role in human energy metabolism, obesity, and diabe-
tes (30). We have previously shown a positive correla-
tion between metabolic rate and UCP3 mRNA expres-
sion in humans (31), although results are conflicting
(2). Furthermore, mice overexpressing UCP3 in skele-
tal muscle are hyperphagic but weigh less than control
mice (7). These data indicate that UCP3 could indeed
play an important role in thermogenesis; however,
several findings regarding the regulation of UCPs do
not match with a role for UCP3 in energy metabolism.
For example, UCP3 mRNA expression is upregulated
during fasting, both in rodents (35) and in humans
(19), whereas in a situation of food deprivation conser-
vation of energy is observed (14). An explanation for
the unexpected upregulation of UCP3 during fasting
comes from the observation that free fatty acids (FFA)
upregulate UCP3 mRNA expression both in rodents
(35) and in humans (15). During fasting and situations
of elevated plasma FFA levels, fat oxidation is also
increased, and it has been suggested that UCP3 is
involved in the handling of lipids as a fuel (25).
During and after acute endurance exercise, energy
expenditure, plasma FFA levels, and substrate oxida-
tion are increased rapidly. The effect of acute endur-
ance exercise on UCP3 mRNA expression has been
studied in rodents, showing a rapid upregulation of
UCP3 mRNA postexercise (9, 32, 36). In humans, few
data are available regarding the effect of acute exercise
on UCP3 mRNA expression. We previously measured
UCP3 mRNA expression before and immediately after
80 min of exhaustive cycling exercise and did not ob-
serve an effect of acute exercise on UCP3 mRNA (29).
Pilegaard et al. (23) observed that UCP3 mRNA was
upregulated 1–4 h after an acute bout of exercise.
However, none of the studies mentioned above have
addressed the possible effect of plasma FFA levels on
UCP3 expression during exercise. Because high
plasma FFA levels are associated with an upregulation
of UCP3 mRNA and exercise is characterized by an
increased level of plasma FFA, it is very well possible
that the exercise-induced upregulation of UCP3 is not
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an exercise effect but an FFA-mediated effect. There-
fore, the aim of the present study was to examine
whether the upregulation of UCP3 mRNA expression
after acute exercise is an effect of exercise per se or an
effect of increased levels of plasma FFA. For this,
UCP3 mRNA expression was measured immediately
after as well as 1 and 4 h after a 2-h exercise bout,
which was performed one time without and one time
with glucose ingestion. We have previously shown that
glucose ingestion results in a marked reduction in FFA
availability and fatty acid oxidation and a marked
increase in plasma glucose levels and glucose oxidation
(10). Because no data are available on the effect of
exercise on UCP3 protein content, we also determined
the latter in the present study.
METHODS
Subjects
Seven healthy, untrained male volunteers participated in
this study. Subject characteristics are shown in Table 1.
None of the subjects participated in endurance sports, but all
were moderately active. The nature and risks of the experi-
mental procedure were explained to the subjects, and all
subjects gave their written informed consent. The study was
approved by the Medical-Ethical Committee of Maastricht
University.
Experimental Design
After an overnight fast, subjects came to the laboratory at
8:00 AM, and a percutaneous muscle biopsy was taken from
the vastus lateralis muscle. After local anesthesia, a 5-mm-
diameter side-cutting needle was passed through a 7-mm
skin incision. The muscle biopsy was frozen immediately in
liquid nitrogen and stored at 280°C until assayed. After this,
a Teflon cannula was inserted in an antecubital vein for
sampling of blood. Subjects rested on a bed, and a baseline
blood sample was taken [baseline, time (t) 5 260 min].
Immediately after the first blood sample was taken, subjects
ingested 1.4 g/kg body wt glucose (dissolved in water to a 20%
solution and flavored with 1 ml lemon juice). At t 5 210, 30,
60, 90, 180, 240, and 300 min, subjects ingested 0.35 g/kg
body wt glucose (dissolved in water to a 10% solution and
flavored with 1 ml lemon juice).
After having rested for 1 h, subjects started exercising at
50% of maximal power output (Wmax; t 5 0 min). The exercise
bout lasted for 2 h, and during exercise blood samples were
taken every 30 min (at t 5 30, 60, 90, and 120 min). Imme-
diately after cessation of the 2 h of exercise, a second muscle
biopsy was taken (t 5 120 min). After the muscle biopsy was
taken, subjects rested on a bed for 4 h, and a third and fourth
muscle biopsy was taken after 1 (t 5 180 min) and 4 (t 5 360
min) h of rest. During this postexercise period, blood samples
were taken every hour (at t 5 180, 240, 300, and 360 min).
The experimental design is depicted in Fig. 1.
Indirect calorimetry was performed continuously at rest
and in the last 10 min of every half-hour during exercise. The
entire protocol was repeated after at least 1 wk but now with
ingestion of equal amounts of water. Subjects started at
random with either the water or the glucose trial.
Procedures
Maximal power output. Before the experiment (1 wk), each
subject performed an incremental exercise test on an electro-
magnetically braked cycle ergometer (Lode Excalibur, Gro-
ningen, The Netherlands) to determine maximal oxygen con-
sumption. Exercise was performed until voluntary
exhaustion or until the subject could no longer maintain a
pedaling rate of $60 rpm. Oxygen consumption (V˙O2) and
carbon dioxide production (V˙CO2) were measured using open
circuit spirometry (Oxycon-b, Mijnhard, The Netherlands).
Muscle biopsy, UCP3 mRNA expression, and UCP3 protein
content. Muscle biopsies were taken from the midthigh region
from the vastus lateralis muscle according to the technique of
Bergstro¨m et al. (3). Part of the biopsy was used for isolation
of total RNA using the acid phenol method of Chomczynski
and Sacchi (6), with an additional DNase digestion step with
concomitant acid-phenol extraction and ethanol precipita-
tion. UCP3L (390-nt-long) and UCP3S (436-nt-long) cDNA
fragments were obtained by RT-PCR. The two competitor
DNAs were obtained by a deletion of 40 bp (20). For the
assay, the RT reaction was performed from 0.2 mg of skeletal
muscle total RNA in the presence of a thermostable reverse
transcription (Promega) by use of one of the specific antisense
primers. The competitive PCR assays were performed as
previously described (19, 20). To improve the quantification
of the amplified products, fluorescent dye-labeled sense oli-
gonucleotides were used. The PCR products were separated
and analyzed on an ALFexpress DNA sequencer (Pharmacia)
with the Fragment Manager Software. Total RNA prepara-
tions and RT-competitive PCR assays of the skeletal muscle
samples from the same individual (before 2 after acute
exercise) were performed simultaneously.
The remaining part of the muscle biopsies was homoge-
nized in ice-cold Tris-EDTA buffer at pH 7.4; thereafter, the
homogenates were sonicated for 3 3 5 s. Subsequently, 2 vol
of each skeletal muscle homogenate and 1 vol of SDS sample
buffer were boiled for 4 min (17). Polyacrylamide gels (12%)
containing 0.1% SDS were loaded with equal amounts of
protein of each sample, and electrophoresis was performed
Table 1. Subjects characteristics
Subject Mean6SE
Age, yr 22.760.6
Height, m 1.7960.03
Weight, kg 76.463.7
BMI, kg/m2 23.861.0
Wmax, W 291614
Wmax/kg, W/kg 3.860.2
V˙O2max, ml/min 3,8526211
V˙O2max, ml zmin21 zkg21 50.562.4
BMI, body mass index; V˙O2max, maximal O2 uptake; Wmax, maxi-
mal power output.
Fig. 1. Experimental design of the study. All subjects performed the
protocol 2 times, 1 time in the fasted state and 1 time with glucose
ingestion.
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using a Mini-Protean 3 Electrophoresis Cell (Bio-Rad Labo-
ratories, Hercules, CA), followed by Western blotting using a
Mini Trans-Blot Electrophoretic Transfer Cell (Bio-Rad Lab-
oratories). The separated polypeptides were transferred to a
nitrocellulose membrane (0.45 mm; Bio-Rad Laboratories) by
blotting for 1 h at 100 V in a cold (4°C) buffer containing 25
mM Tris, 192 mM glycine, and 20% methanol.
After protein transfer, nitrocellulose sheets were blocked
with 5% nonfat dry milk in 0.05% Tween 20-PBS; thereafter,
antibody incubation was performed by gentle shaking over-
night at room temperature at a dilution of 1:5,000 in 5%
nonfat dry milk in 0.05% Tween 20-PBS. A rabbit polyclonal
UCP3 antibody (code:1331, kindly provided from L. J.
Slieker, Eli Lilly) prepared against a 20-amino acid peptide
(human sequence amino acids 147–166) that recognizes both
the long and the short form of UCP3 and previously was
shown not to recognize UCP2 was used (12). The antibody
was affinity purified on a Sulfolink column (Pierce, Omnilabo
International, Breda, The Netherlands) containing the pep-
tide coupled through a COOH-terminal Cys. Cross-reaction
of the antibody with other proteins was checked for by exam-
ining the entire 5- to 94-kDa range for additional bands. The
molecular mass of the band visualized by chemiluminescence
was compared with reference values.
After antibody incubation, the blots were incubated for 60
min with horseradish peroxidase-conjugated swine anti-rab-
bit Ig (Dako) at a dilution of 1:10,000. The blots were washed
for 2 h in 0.05% Tween 20-PBS and treated for 1 min with
chemiluminescence substrate (Super Signal West Dura Ex-
tended Duration Substrate; Pierce). Finally, a clear blue
X-ray film (CL-Xposure Film; Pierce) was exposed to the
nitrocellulose sheets for 1 min. The reaction product of each
blot was analyzed by densitometry using Imagemaster
(Pharmacia Biotech).
Blood Analysis
Blood was collected in tubes containing EDTA to prevent
clotting and immediately centrifuged at 4,000 rpm for 10 min
at 4°C. Plasma was frozen in liquid nitrogen and stored at
280°C. Plasma substrates were determined using the hex-
okinase method (Roche, Basel, Switzerland) for glucose and
the Wako NEFA C test kit (Wako Chemicals, Neuss, Ger-
many) for FFA.
Calculations
From the recorded V˙O2 and V˙CO2 (Oxycon-b), carbohydrate
and fat oxidation rates and energy expenditure were calcu-
lated using the formulas of Pe´ronnet and Masssicotte (22).
Statistical Analysis
Repeated-measures ANOVA was performed to examine
differences in measured parameters between the glucose and
fasted treatment at any time point. Two-way ANOVA was
performed to examine interaction between time and treat-
ments. For comparing overall differences between treat-
ments, areas under the curve were calculated for t 5 30 to t 5
120 min during exercise and for t 5 180 to t 5 360 min
postexercise. Pearson correlation coefficients were calculated
to determine the relationship between selected variables. All
data are presented as means 6 SE, and a P value ,0.05 was
considered statistically significant.
RESULTS
Energy Expenditure and Substrate Oxidation
There were no significant differences in energy ex-
penditure between the glucose treatment and the
fasted state at baseline, during exercise, or postexer-
cise (Table 2).
The respiratory quotient was significantly higher
(P , 0.05) at every time point with the glucose treat-
ment compared with the fasted state (Fig. 2). The area
under the respiratory quotient vs. time curve was sig-
nificantly higher with the glucose treatment compared
with the fasted state during both exercise and postex-
ercise (P , 0.05). Carbohydrate oxidation was signifi-
cantly higher (P , 0.05) and fat oxidation was signifi-
cantly lower (P , 0.05) at every time point with the
glucose treatment compared with the fasted state (Ta-
ble 2). During exercise, fat oxidation increased between
t 5 30 and t 5 120 min in both conditions (P , 0.001),
but there was no time vs. treatment interaction. Car-
bohydrate oxidation decreased between t 5 30 and t 5
120 min with the glucose treatment (P , 0.05),
whereas this decrease between t 5 30 and t 5 120 min
in the fasted state was almost significant (Table 2, P 5
0.06). In both conditions, carbohydrate and fat oxida-
tion reached a steady state postexercise. The area
under the carbohydrate oxidation vs. time curve was
significantly higher with the glucose treatment com-
pared with the fasted state during both exercise and
postexercise (P , 0.05), whereas the area under the fat
oxidation vs. time curve was lower with the glucose
treatment compared with the fasted state (P , 0.05).
Table 2. Energy expenditure and fat and carbohydrate oxidation during and after exercise
in the glucose and fasted treatment
Treatment
Time,
min
Glucose Fasted
EE, kJ/
min
Fat oxidation,
mg/min
CHO oxidation,
mg/min
EE, kJ/
min
Fat oxidation,
mg/min
CHO oxidation,
mg/min
Exercise 0* 6.460.2 88624.2 159658† 5.560.2 8769 107626
30 45.062.0 459641† 1,478646† 44.361.6 617641 1,081696
60 45.662.2 529649† 1,353656† 45.761.9 682638 1,0076113
90 46.762.5 535653† 1,400679† 45.962.0 740646 887685
120 46.562.7 607667† 1,2426104† 46.662.6 732655 828685
Postexercise 180 6.160.2 4569† 241613† 5.960.2 11066 79615
240 5.960.2 5468† 207613† 6.060.2 11267 7968
300 5.760.3 5268† 203621† 5.860.2 11966 5269
360 5.960.2 4864† 221616† 5.760.2 10166 9267
Data are means 6 SE. EE, energy expenditure; CHO, carbohydrate. *Measured after glucose ingestion. †P , 0.05 compared with fasted
treatment.
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Blood Analysis
Plasma FFA concentration (Fig. 3A) was signifi-
cantly lower at every time point with the glucose treat-
ment compared with the fasted state (P , 0.05). Dur-
ing exercise, plasma FFA concentration gradually
increased in the fasted state (P , 0.0001), whereas in
the glucose treatment an initial decline in plasma FFA
levels was present (319 6 19 vs. 135 6 13 at baseline
and t 5 30 min, respectively, P , 0.05). After the initial
decline, plasma FFA levels also gradually increased
with the glucose treatment (P , 0.001). There was a
significant time vs. treatment interaction (P , 0.0001),
indicating that plasma FFA levels increased signifi-
cantly more in the fasted state compared with the
glucose treatment during exercise. Postexercise
plasma FFA levels were in a steady state in both
conditions. The area under the plasma FFA level vs.
time curve was significantly higher during both exer-
cise and postexercise in the fasted state compared with
the glucose treatment. Plasma glucose concentration
(Fig. 3B) was significantly higher during exercise at t 5
90 and 120 min and 1 (t 5 180 min) and 4 (t 5 360 min)
h postexercise (P , 0.05) with the glucose treatment
compared with the fasted state. During exercise,
plasma glucose concentration gradually decreased in
the fasted state (P , 0.0001), whereas with the glucose
treatment plasma glucose levels significantly in-
creased between t 5 30 and t 5 120 min (P , 0.001).
There was a significant time vs. treatment interaction
(P , 0.0001). Postexercise plasma glucose levels were
in a steady state in the fasted state, whereas with the
glucose treatment plasma glucose was decreased 3 h
postexercise (at t 5 300 min) compared with 1 h post-
exercise (t 5 180 min, P 5 0.03). During both exercise
and postexercise, the area under the plasma glucose
levels vs. time curve tended to be significantly higher
with the glucose treatment compared with the fasted
state (P 5 0.055).
Effect of Acute Exercise on UCP3 mRNA and UCP3
Protein Content
At baseline, UCP3 mRNA expression and UCP3 pro-
tein content were not significantly different between
the glucose treatment and fasted state. Acute exercise
had no immediate effect on UCP3L mRNA expression.
However, in the fasted state, UCP3L mRNA expression
was increased significantly with, on average, ;106%
4 h postexercise (t 5 360 min) compared with baseline,
immediately after exercise (t 5 120 min), and 1 h
postexercise (t 5 180 min; P , 0.05, Fig. 4). With the
glucose treatment, no differences in UCP3L mRNA
expression were observed (P 5 0.43). UCP3L mRNA
expression tended to be higher in the fasted state
compared with glucose treatment 4 h postexercise (at
t 5 360 min, P 5 0.07). No differences in UCP3S
mRNA expression between conditions and/or time
Fig. 2. Respiratory quotient (RQ) during and after 2 h of cycling at
50% maximal power output (Wmax), with and without glucose inges-
tion. *P , 0.05 compared with fasting. Data are means 6 SE.
Fig. 3. Plasma levels of free fatty acid (FFA; A) and glucose (B)
during and after 2 h of cycling at 50% Wmax, with and without
glucose ingestion. *P , 0.05 compared with fasting. #P , 0.05
compared with glucose. Data are means 6 SE.
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points were observed (Table 3). UCP3 protein content
did not change significantly during or after exercise in
any of the conditions and was not significantly differ-
ent between the glucose treatment and fasted state at
any time point measured (Table 3).
DISCUSSION
Acute exercise has been shown to result in an up-
regulation of UCP3 mRNA expression (9, 23, 32, 36).
Acute exercise also results in an increase in plasma
FFA levels, and it has been shown that FFA upregulate
UCP3 mRNA expression (15, 35). In the present study,
we examined the effect of 2 h of moderate-intensity
exercise on UCP3 mRNA in two different situations
(with high and low plasma FFA levels). The data show
clearly that this exercise regime resulted in an upregu-
lation of UCP3L mRNA, but only when plasma FFA
were elevated for several hours. Acute exercise without
elevation of plasma FFA levels, but with high plasma
glucose levels and glucose oxidation, does not lead to
significant changes in UCP3L mRNA expression in
muscle. The short isoform of UCP3, which lacks the
last coding exon, was not upregulated in either treat-
ment. UCP3S mRNA likely results in a truncated pro-
tein, lacking the sixth transmembrane domain (4) and
possibly leading to altered uncoupling activity. How-
ever, the precise function of the two isoforms is pres-
ently unknown. Furthermore, the upregulation of
UCP3L mRNA was not accompanied by changes in
UCP3 protein content over this 4-h postexercise period,
suggesting that the translation of UCP3 mRNA into
protein requires more than these 4 h. This is not
surprising when it is considered that the half-life of
UCP1 protein, a mitochondrial protein with high ho-
mology to UCP3, is ;5 days, which would indicate that
several days are needed for changes in mRNA to be-
come evident as changes in protein (21). Taken to-
gether, our results show that the effect of a 2-h exercise
bout of moderate intensity on UCP3L mRNA is not an
exercise effect per se but rather a fat metabolism-
mediated effect.
The function of human UCP3 is presently unknown.
Because UCP3 is expressed specifically in skeletal
muscle in humans (4) and because skeletal muscle is
known to be an important thermogenic organ (1),
UCP3 has been considered to be involved in human
energy metabolism. Acute exercise is characterized by
marked increases in energy expenditure, both during
and after the exercise bout. Therefore, the effect of
acute exercise on UCP3 expression has been investi-
gated previously. Zhou et al. (36) showed that UCP3
mRNA expression was upregulated sevenfold after 30
min of treadmill running in rats. Similarly, Cortright
et al. (9) observed that, after 1 h of treadmill running,
UCP3 mRNA expression was elevated 63 and 252% in
red and white gastrocnemius muscle, respectively.
Tsuboyama-Kasaoka et al. (32) showed that UCP3
mRNA levels in rats were upregulated 3 h after 1 h of
swimming but returned to baseline 22 h postexercise.
In humans, Pilegaard et al. (23) showed that UCP3
mRNA was upregulated 4 h after acute exercise. These
data are consistent with a role for UCP3 in the regu-
lation of energy metabolism. However, there are also
data that seem to be incompatible with the concept of
energy dissipation. For example, UCP3 expression in
skeletal muscle is increased during fasting (19, 24), an
energy turnover-attenuating condition. Because UCP3
also increases upon high-fat feeding (35) and fasting
results in elevated levels of plasma FFA levels, it has
been suggested that changes in fatty acid metabolism
are responsible for the increased UCP3 expression dur-
ing fasting and high-fat feeding. According to some
theories, the uncoupling function of UCP3 involves the
outward transport of fatty acid anions across the inner
mitochondrial membrane (13). This also suggests that
it is not necessarily the amount of plasma FFA that
determines the expression of UCP3 but rather the
delivery of fatty acids to the mitochondria or the con-
centration of fatty acids inside the mitochondria. In-
Table 3. UCP3S mRNA expression and UCP3 protein
content during and after exercise in the glucose and
fasted treatment
Time,
min
UCP3S mRNA,
amol/mg RNA UCP3 Protein, AU
Glucose Fasted Glucose Fasted
260 2.860.4 5.861.9 1.260.3 1.260.2
120 2.260.7 4.761.9 1.160.2 0.960.2
180 3.460.7 4.461.7 0.960.1 1.260.2
360 3.861.1 5.562.0 1.060.2 0.960.1
Data are means 6 SE. UCP, uncoupling protein; UCP3S, short
isoform of UCP3; AU, arbitrary units.
Fig. 4. Skeletal muscle mRNA expression of the long isoform of
uncoupling protein (UCP)3 (UCP3L) during and after 2 h of cycling
at 50% Wmax, with and without glucose ingestion. #P 5 0.07 com-
pared with glucose. ¥P , 0.05 compared with t 5 260, 120, and 180
min in fasted treatment only. Data are means 6 SE.
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hibiting fatty acid oxidation by administration of eto-
moxir, a blocker of carnitine palmitoyltransferase I
(the rate-limiting enzyme for uptake of fatty acids by
the mitochondria), results in a decrease in UCP3
mRNA expression, even though plasma FFA levels are
high (25). This suggests that UCP3 expression could be
related to fatty acid oxidation. Further evidence for the
latter comes from our recent finding (27) that UCP3
mRNA expression was upregulated after consumption
of a high-fat diet for 4 wk, which is known to result in
an increase in fatty acid oxidation, whereas plasma
FFA levels are known to be unaltered after long-term
high-fat diets (26, 27).
Because acute exercise not only results in an in-
crease in energy expenditure but also increases plasma
FFA levels and fat oxidation, we examined in the
present study whether the increase in UCP3 mRNA
after acute exercise could be more directly related to
changes in fat metabolism instead of to changes in
energy metabolism. We found that the effect of 2 h of
moderate-intensity exercise on UCP3 mRNA expres-
sion is not a direct effect of exercise per se but rather
an effect of sustained elevated plasma FFA levels
and/or increased fatty acid oxidation. Because there
was no difference in energy expenditure between the
fasted and glucose treatments, the results show that
the upregulation of UCP3L after exercise does not
seem to be related to exercise-induced changes in en-
ergy metabolism. This might indicate, but does not
necessarily prove, that the primary function of skeletal
muscle UCP3 during exercise is not related to the
regulation of energy metabolism. Alternatively, UCP3
might play a role in fatty acid metabolism. We recently
postulated a hypothesis concerning an alternative
function for UCP3 (28). In short, small amounts of
neutral fatty acids are believed to be able to cross
membranes by flip-flop (11), and neutral fatty acids
might thus reach the mitochondrial matrix. The entry
of fatty acids into the mitochondrial matrix via flip-flop
might be particularly true in situations when fatty acid
flux in the cells exceeds the capacity to metabolize
these fatty acids and thus fatty acid concentrations
inside the cells would start to increase, as can be
expected to be the case in the present study. Because
the fatty acids that enter the mitochondrial matrix will
be deprotonated (because of the proton gradient) and
because fatty acid anions are not able to flip-flop (11),
we hypothesize that UCP3 might be involved in the
outward translocation of fatty acid anions across the
inner mitochondrial membrane. Note that, as a result,
UCP3 would lower the proton gradient across the inner
mitochondrial membrane, explaining the previously
observed relation between UCP3 and energy metabo-
lism (5, 7, 31, 34). The results from the present study
are compatible with this hypothesis, but further stud-
ies are necessary to examine this putative function of
UCP3.
Another postulated function of UCP3 is defense
against reactive oxygen species (ROS; see Ref. 33). It
has been shown that an increase in mitochondrial
membrane potential results in the formation of ROS
(16). Furthermore, ROS formation is increased during
and after exercise (8). Because UCP3 decreases mito-
chondrial membrane potential, high levels of UCP3
during and after exercise could be helpful in the pre-
vention of the formation of ROS. Therefore, an upregu-
lation of UCP3 after acute exercise would be consistent
with a role for UCP3 in the defense against oxidative
stress. However, our finding that UCP3 is not upregu-
lated after acute exercise in the glucose-treated condi-
tion would implicate that either UCP3 does not play a
role in the defense of ROS formation or that the exer-
cise-induced formation of ROS is lower in the glucose-
fed state. Indeed, high intracellular levels of fatty acids
result in increased ROS formation, and it might thus
be that UCP3 specifically plays a role in preventing
fatty acid-induced ROS formation (18). As stated
above, we hypothesize that UCP3 is upregulated in
situations when fatty acid flux into the mitochondria
exceeds the capacity to metabolize these fatty acids
and would thereby both reduce ROS formation and, by
translocating the fatty acid anions across the mito-
chondrial membrane out of the matrix, prevent these
fatty acids from lipid peroxidation.
In conclusion, we found that 2 h of exercise at mod-
erate intensity had no direct effect on UCP3L mRNA
expression. Abolishing the commonly observed in-
crease in plasma FFA levels and/or fatty acid oxidation
during and after exercise also prevented the upregula-
tion of UCP3L after exercise. These results suggest
that UCP3 is involved in fatty acid metabolism and is
upregulated in situations when fatty acid flux into the
mitochondria exceeds the capacity to metabolize these
fatty acids. A possible function for UCP3 might be to
reduce ROS formation and, by translocating the fatty
acid anions across the mitochondrial membrane out of
the matrix, prevent these fatty acids from lipid peroxi-
dation. However, further studies are needed to test this
hypothesis.
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